Name

Reproart Clinic

Legal name

GEORGIAN-AMERICAN CENTER FOR REPRODUCTIVE MEDICINE REPROART LTD

Website

https://reproart.ge

Company type

Private

Founded year

2012

Operating status

Operating

Headcount range

51–100 employees

Ownership category

akta.pro rank

Product category

Reproductive Medicine / Fertility Services

NAICS

Medical and Diagnostic Laboratories (6215), Family Planning Centers (621410)

SIC

Services-Offices & Clinics Of Doctors Of Medicine (8011), Services-Specialty Outpatient Facilities, Nec (8093), Services-Medical Laboratories (8071)

akta.pro primary industry

Fertility, Reproductive Endocrinology & IVF Centers (HLAFAJAD)

akta.pro secondary industries

Reproductive Endocrinology & Infertility (IVF/Fertility) (HLAKAJAC), Male Reproductive & Sexual Medicine (Andrology) (HLAKAOAD), Prenatal, Newborn & Reproductive Diagnostics (NIPT, IVF/PGT, newborn screening) (HLAAALAJ)

Keywords

• Fertility treatment services
• In vitro fertilization
• Assisted reproductive technology
• Egg donation programs
• Surrogacy services

Headquarters

HQ city

Tbilisi

HQ country

Georgia

HQ region

Asia

Offices3 records

Markets served

GTM type

B2C

Offering type

Services

Cost components

Personnel, Operations, Technology or R&D, Infrastructure, Marketing or Sales, Supply Chain

Revenue model

1. IVF Treatment Services: In vitro fertilization treatment cycles including ovarian stimulation, egg retrieval, fertilization, and embryo transfer
2. Surrogacy Programs: Full surrogacy programs including guaranteed baby programs, egg donation, and surrogacy with own biomaterial
3. Egg Donation: Egg donation program with 70% success rate
4. Sperm Donation: Sperm donation using international sperm bank samples
5. Cryopreservation Services: Embryo, oocyte, and semen freezing and storage services
6. Genetic Testing: PGT-A, PGT-M, carrier screening, and cytogenetic testing

Pricing tiers

Go-to-market motion2 records

Distribution channels2 records

Marketing channels6 records

Core offering

ReproART Clinic is a Georgian-American reproductive medicine center providing a comprehensive suite of clinical fertility services: in vitro fertilization (IVF), intracytoplasmic sperm injection (ICSI), intrauterine insemination (IUI), egg and sperm donation, surrogacy programs (including a Guaranteed Baby Program), embryo/oocyte/semen cryopreservation, surgical sperm retrieval, fertility preservation, and preimplantation genetic testing (PGT-A, PGT-M, carrier screening, karyotyping). The clinic operates three branches in Georgia and an in-house Genomics Center for genetic diagnostics.

Product overview

Reproart Clinic is a Georgian-American reproductive medicine center offering a comprehensive suite of assisted reproductive technology services. The core offerings include IVF (In Vitro Fertilization) with 57-86% success rates, ICSI for male factor infertility, and various cryopreservation services (embryo, oocyte, and semen freezing). The clinic provides genetic testing services including PGT-A for aneuploidy screening, PGT-M for monogenic diseases, carrier screening, and cytogenetic testing. Additional services include egg and sperm donation programs, surrogacy with a Guaranteed Baby Program (83% success rate), fertility preservation for medical reasons, pregnancy planning with natural cycle monitoring, and a full-service clinical diagnostic laboratory.

Differentiator

Problem solved

Functional benefit

Brands

• Genomics: High-tech biomedical research and genetic diagnostics center opened in 2020, focused on reproductive genetics including PGT-A testing

Products and services

• IVF – In Vitro Fertilization Assisted reproductive technology (ART) for infertility treatment involving collecting eggs from the woman and combining them with a male sperm sample in a laboratory, followed by embryo transfer to the uterus. At ReproART, 57-86% of IVF cases result in a positive pregnancy test. Targeted at heterosexual couples facing infertility.
• ICSI – Intracytoplasmic Sperm Injection A specialized fertilization procedure in which a single sperm is injected directly into an oocyte's cytoplasm with a glass micropipette under a microscope, used for male factor infertility. The clinic achieves an 80% fertilization rate in its laboratory.
• IUI – Intrauterine Insemination Procedure where processed sperm are injected through the cervix directly into the uterine cavity around ovulation, either in a natural cycle or with ovarian stimulation medications. Used for milder infertility cases.
• Surgical Sperm Retrieval Microsurgical procedures including PESA (Percutaneous epididymal sperm aspiration), TESA (Testicular sperm aspiration), TESE (Testicular sperm extraction), and MESE (Microsurgical testicular sperm extraction) for males with azoospermia. The clinic reports a 65% motile sperm retrieval rate.
• Embryo Freezing (Vitrification) Cryopreservation of embryos using vitrification — rapid freezing in liquid nitrogen at -196°C. The clinic achieves a 98% survival rate for thawed blastocysts and a 64.5% pregnancy rate after frozen embryo transfer.
• Oocyte Freezing Egg freezing procedure using vitrification. The clinic reports a 90% survival rate for thawed oocytes and 60% of egg thaw procedures leading to pregnancy for women who froze oocytes at a younger age.
• Semen Cryopreservation Freezing and storage of sperm samples using cryoprotectant solutions at -196°C. Frozen semen can be stored indefinitely and remains useful for reproductive procedures.
• PGT-A – Preimplantation Genetic Testing for Aneuploidy Examination of embryo chromosome number before transfer to identify euploid (healthy) embryos with 46 chromosomes. Enables selection of embryos compatible with life, reduces miscarriage rates, and triples pregnancy chances in women aged 40+.
• PGT-M – Preimplantation Genetic Testing for Monogenic Diseases Test designed to lower the risks of passing hereditary genetic diseases to a child, used when couples are at risk of having a child affected by single gene modification disorders.
• Carrier Screening Test Genetic test for family planning that determines the risk of having a child with a genetic disease and shows whether future parents are carriers of recessive genetic mutations. Studies 549 different genes responsible for over 600 monogenic genetic disorders.
• Cytogenetic Testing (Karyotyping) Chromosome analysis recommended for diagnosing genetic contributions in cases of stillbirth, growth delay, dysmorphic features, multiple malformations, intellectual disability, and advanced maternal age pregnancy.
• Egg Donation Program recommended when a woman does not have viable eggs or egg quality precludes pregnancy. Includes donor selection, medical examinations, ovarian stimulation, and egg retrieval. The clinic achieves a 70% success rate with donor eggs.
• Sperm Donation Use of sperm from international sperm banks when the male partner has no sperm, has genetic disorders, or whose sperm cannot fertilize eggs. Donors undergo complex medical and psychological screening with a 6-month quarantine.
• Surrogacy (Guaranteed Baby Program) Program where surrogate mothers carry and give birth to children for biological parents. Includes a Guaranteed Baby Program that guarantees multiple IVF attempts until a successful live birth. The clinic reports an 83% success rate for surrogacy, served patients from over 27 countries, and has produced over 4,000 babies cumulatively.
• Fertility Preservation Cryopreservation of sperm, eggs, or embryos prior to cancer treatment (chemotherapy or radiation therapy) to preserve reproductive potential. Includes coordination with oncologists for timely preservation.
• Pregnancy Planning Natural cycle monitoring service where a fertility specialist identifies favorable days for pregnancy through ultrasound monitoring and hormonal testing, allowing pregnancy planning without assisted reproductive technology.
• Clinical Diagnostic Laboratory Full-service laboratory offering complete blood tests, biochemical and hormone analyses with automated analyzers for precision. Can provide hormone analysis results in just one hour upon request.

Quantifiable outcome

• 70% success rate with egg donation program
• +5 more outcomes

Named customers2 records

Segments4 records

Ideal customer profiles3 records

Technology focussed No

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Feature4 records

Partnerships

Seven partnerships are on record, tiered core and minor.

• Genomics CentercoreStrategic or Co-development Partner · 1 January 2020In-house biomedical research and genetic diagnostics center opened in 2020 focused on reproductive genetics. Performs PGT-A and other genetic testing for embryos with fast turnaround times.
• Armenia DestinationminorStrategic or Co-development PartnerReproART expanding globally with Armenia destination for surrogacy services. Armenia provides flexible and legally secure environment including options for unmarried couples and single parents.
• International Sperm BankscoreOthersFrozen sperm samples sourced from international sperm banks meeting European and American certification standards. Donors undergo comprehensive medical and genetic screening.
• Jones Institute for Reproductive MedicinecoreStrategic or Co-development PartnerWhere the first IVF baby in the US was born. Lika Chkonia trained at Susan Lanzendorf Lab at Jones Institute. Dr. David McCulloh maintains connections as part of professional network.
• New York University Fertility Center (NYUFC)coreStrategic or Co-development PartnerDr. David McCulloh serves as Assistant Laboratory Director and Research Committee Chair at NYUFC. Partnership includes electronic medical record system (Redshift Technologies) and ongoing research collaboration.
• Surrogacy and Egg Donation AgencycoreChannel Partner/ Reseller/ DistributorAgency providing surrogate mother matching and egg donor database. Coordinates surrogacy arrangements for international intended parents.
• UK and US Genetic Testing LaboratoriescoreTechnology or IntegrationBiopsied embryo cells sent to partner laboratories in Great Britain and United States for PGT-A genetic testing with active cooperation maintained.

Scale indicators10 records

Recent moves9 records

Expansion highlights5 records

Direct peers

• BioTexCom: Ukraine-based fertility and surrogacy clinic historically serving large volumes of international intended parents with cross-border surrogacy and IVF packages — the closest functional comparison to ReproART's medical-tourism model and Georgia-adjacent positioning.
• Institute of Life (IASO Maternity Hospital): Greek reproductive medicine center offering IVF, egg donation, and PGT to a primarily international patient base — directly comparable geography and cross-border positioning.
• Newlife IVF Greece: Greek fertility clinic targeting international patients with IVF, egg donation, and surrogacy-adjacent services; competes with ReproART for European and cross-border fertility tourism volume.
• IVF Spain: Spain-based fertility clinic marketing to international patients with IVF, PGT, and donor egg programs — a direct cross-border competitor in the European fertility-tourism segment.
• Gynem Fertility Clinic: Czech Republic fertility clinic specializing in IVF, egg donation, and fertility tourism for international patients — overlapping service mix and comparable international-patient GTM.

Broad incumbents

• Institut Marquès: International fertility center headquartered in Barcelona with cross-border egg donation and IVF programs — competes for the same European and international patient segments as ReproART.
• IVI-RMA Global: World's largest fertility treatment network with full ART and genetic testing services across Europe, Latin America, and the Middle East — overlapping clinical capabilities and target patients but at a materially larger scale.
• Bourn Hall Fertility Clinic: Historic UK IVF clinic (birthplace of the world's first IVF baby) offering full ART and PGT services — comparable clinical scope but operating in a different regulatory and patient-mix environment.
• CCRM Fertility: Large US fertility clinic network with strong PGT and embryology capabilities; competes for high-end international patients seeking US-standard treatment.
• Genea Biomedx / Genea Fertility: Australian fertility group with global embryology and lab-monitoring technology plus patient services — overlaps on ART service mix and advanced embryology.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat5 records

Key risks6 records

Key highlights7 records

Customer concentration

• YouTubeyoutube.com/@ReproARTClinic
• Facebookfacebook.com/reproartclinic
• LinkedInlinkedin.com/company/reproart-clinic

Revenue estimate

Valuation estimate

Number of profiles

Profiles3 records

Subsidiaries1 record

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Reproart Clinic